Mississippi Oncology Society

Mississippi Oncology Society We are an association that supports physicians and the entire medical team involved in the treatment

11/19/2025

On November 19, 2025, the Food and Drug Administration granted accelerated approval to sevabertinib.

11/19/2025

On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle (Imdelltra, Amgen Inc.) for adults with extensive stage s

11/19/2025

On November 19, 2025, the Food and Drug Administration granted traditional approval to daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech Inc.

11/19/2025

On November 19, 2025, the Food and Drug Administration approved selumetinib (KOSELUGO, AstraZeneca Pharmaceuticals LP) for adults with neurofibromatosis type 1

11/18/2025

FDA approves epcoritamab-bysp for follicular lymphoma indications

11/13/2025

On November 13, 2025, the Food and Drug Administration approved Poherdy (pertuzumab-dpzb, Shanghai Henlius Biologics Co. Ltd.) as an interchangeable biosimilar

11/13/2025

On November 13, 2025, the Food and Drug Administration approved ziftomenib (Komzifti, Kura Oncology, Inc.).

11/07/2025

On November 6, 2025, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-

Address

574 E Ritchie Highway #271
Severna Park, MD
21146

Alerts

Be the first to know and let us send you an email when Mississippi Oncology Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category